Skip to main content
. Author manuscript; available in PMC: 2018 Jun 6.
Published in final edited form as: J Endocrinol Diabetes. 2018 May 10;5(2):10.15226/2374-6890/5/2/01102.

Figure 2.

Figure 2

Diabetic Parkinson’s disease (n=2) or dementia autoantibodies (n=1) caused significant suppression of N2A cell neurite extension compared to control cells (A); Mean N2A neurite length suppression induced by three different diabetic PD autoantibodies was nearly completed prevented by co-incubation with 200 nM M100907, a highly selective 5-HT2A receptor antagonist (B). Potent, time-dependent suppression of N2A neurite outgrowth by diabetic dementia (Pt 1) autoantibodies was partially prevented by co-incubation with M100907(C).